IBEF: June 10, 2016
United Nations: Indian pharmaceutical firms supply over 80 per cent of the antiretroviral drugs used globally to combat AIDS (Acquired Immuno Deficiency Syndrome), while the low-cost generic medicines have helped scale up access to HIV (Human Immunodeficiency Virus) treatment across developing countries, stated Mr J P Nadda, Minister of Health and Family Welfare, while addressing the high-level General Assembly meeting on HIV/AIDS. The UN General Assembly has adopted a new political declaration which emphasises on the critical importance of affordable medicines to combat HIV/AIDS. J P Nadda further stated that developed countries must enhance their commitments to fight the worldwide scourge as international community cannot afford a rebound of the AIDS epidemic. HIV infections in India have reduced by 66 per cent since 2000, while deaths due to AIDS have been reduced by nearly 55 per cent since 2007. Access to affordable medicines and commodity security can help save millions of lives around the world.
Disclaimer: This information has been collected through secondary research and IBEF is not responsible for any errors in the same.